Literature DB >> 32769628

Perfusate Analysis During Dual Hypothermic Oxygenated Machine Perfusion of Liver Grafts: Correlations With Donor Factors and Early Outcomes.

Damiano Patrono1, Giorgia Catalano1, Giorgia Rizza1, Nicola Lavorato1, Paola Berchialla2, Alessandro Gambella3, Paola Caropreso4, Giulio Mengozzi4, Renato Romagnoli1.   

Abstract

BACKGROUND: Liver graft viability assessment has long been considered a limit of hypothermic oxygenated machine perfusion (HOPE). Aim of this study was assessing correlations of easily available perfusate parameters (PP) (aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, glucose, lactate, and pH) with graft features and outcome.
METHODS: In the period October 2018-February 2020, perfusate samples were obtained every 30 minutes during 50 dual-HOPE (D-HOPE) procedures. Correlations of PP with graft factors, 90-day graft loss, early allograft dysfunction (EAD), L-GrAFT score, acute kidney injury, and comprehensive complication index were analyzed using Pearson coefficient, receiver-operating characteristics analysis and by univariable and multivariable regression.
RESULTS: Median D-HOPE time was 122 minutes. All parameters were normalized to liver weight. Only macrovesicular steatosis (MaS) significantly impacted PP levels and slope. Grafts with ≥30% MaS exhibited significantly different PP values and slope. Graft loss and EAD rate were 2% (n = 1) and 26% (n = 13). All PP except lactate correlated with EAD, 90-minute alanine aminotransferase showing the highest area under the receiver-operating characteristics curve (0.84). However, at multivariable analysis, the only factor independently associated with EAD was MaS (odds ratio, 5.44; confidence interval, 1.05-28.21; P = 0.04). Ninety minutes lactate dehydrogenase had the strongest correlation with L-GrAFT (R = 0.70; P < 0.001). PP correlated poorly with comprehensive complication index and grades 2-3 acute kidney injury rate.
CONCLUSIONS: PP were predictive of graft function after transplant, but their association with graft survival and clinical outcomes requires further evaluation. MaS influenced levels of PP and was the only independent predictor of EAD.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32769628     DOI: 10.1097/TP.0000000000003398

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

1.  Clinical assessment of liver metabolism during hypothermic oxygenated machine perfusion using microdialysis.

Authors:  Damiano Patrono; Dorotea Roggio; Anna Teresa Mazzeo; Giorgia Catalano; Elena Mazza; Giorgia Rizza; Alessandro Gambella; Federica Rigo; Nicola Leone; Vincenzo Elia; Daniele Dondossola; Caterina Lonati; Vito Fanelli; Renato Romagnoli
Journal:  Artif Organs       Date:  2021-09-21       Impact factor: 2.663

2.  Heterogeneous indications and the need for viability assessment: An international survey on the use of machine perfusion in liver transplantation.

Authors:  Damiano Patrono; Davide Cussa; Federica Rigo; Renato Romagnoli
Journal:  Artif Organs       Date:  2021-09-08       Impact factor: 2.663

Review 3.  Sense and Sensibilities of Organ Perfusion as a Kidney and Liver Viability Assessment Platform.

Authors:  Laurence Verstraeten; Ina Jochmans
Journal:  Transpl Int       Date:  2022-03-14       Impact factor: 3.782

Review 4.  Viability Assessment in Liver Transplantation-What Is the Impact of Dynamic Organ Preservation?

Authors:  Rebecca Panconesi; Mauricio Flores Carvalho; Matteo Mueller; David Meierhofer; Philipp Dutkowski; Paolo Muiesan; Andrea Schlegel
Journal:  Biomedicines       Date:  2021-02-07

5.  Outcome of liver transplantation with grafts from brain-dead donors treated with dual hypothermic oxygenated machine perfusion, with particular reference to elderly donors.

Authors:  Damiano Patrono; Davide Cussa; Veronica Sciannameo; Elena Montanari; Rebecca Panconesi; Paola Berchialla; Mirella Lepore; Alessandro Gambella; Giorgia Rizza; Giorgia Catalano; Stefano Mirabella; Francesco Tandoi; Francesco Lupo; Roberto Balagna; Mauro Salizzoni; Renato Romagnoli
Journal:  Am J Transplant       Date:  2022-02-22       Impact factor: 9.369

Review 6.  Mitochondria and Cancer Recurrence after Liver Transplantation-What Is the Benefit of Machine Perfusion?

Authors:  Alessandro Parente; Mauricio Flores Carvalho; Janina Eden; Philipp Dutkowski; Andrea Schlegel
Journal:  Int J Mol Sci       Date:  2022-08-28       Impact factor: 6.208

Review 7.  Machine Perfusion for Extended Criteria Donor Livers: What Challenges Remain?

Authors:  Jeannette Widmer; Janina Eden; Mauricio Flores Carvalho; Philipp Dutkowski; Andrea Schlegel
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.